T0	Participants 514 565	Twenty-six patients with relapsed Hodgkin's disease
T1	Participants 594 686	Their median age was 31 years (range, 22-59) and 14 patients were males and 12 were females.
T2	Participants 687 828	Patients were pretreated with a median of eight cycles of cytotoxic chemotherapy, while 18 patients had undergone extended field irradiation.
T3	Participants 2312 2343	patients with Hodgkin's disease